Larisa Cavallari, Pharm.D., BCPS, FCCP, was honored Oct. 26, with the 2020 Distinguished Investigator Award from the American College of Clinical Pharmacy’s Cardiology Practice and Research Network, or PRN. The award is presented annually to a Cardiology PRN member who has made significant and long-lasting research contributions to the field of cardiovascular pharmacotherapy.
Cavallari, an associate professor of pharmacotherapy and translational research in the University of Florida College of Pharmacy, focuses her research around the discovery of genetic associations with drug response, the translation of pharmacogenetic evidence into clinical practice and the examination of clinical pharmacogenetic implementation outcomes. She serves as director of the UF Center for Pharmacogenomics and Precision Medicine, director of the UF Health Precision Medicine Program in Gainesville and is a Board Certified Pharmacotherapy Specialist and a Fellow of the American College of Clinical Pharmacy, or ACCP. She has authored over 150 peer-reviewed publications, and her research has been funded by the National Institutes of Health, the U.S. Food and Drug Administration, the American Heart Association and other agencies.
The Cardiology PRN consists of students, residents, fellows, clinical pharmacists and other practitioners interested in cardiovascular disorders. It is one of the ACCP’s largest PRNs and works to advance the pharmacotherapy of cardiovascular disorders through promoting excellence in education, research and clinical practice by enhancing its members’ knowledge, skills and productivity. Cavallari has been a member of the network since 1997. She was recognized in 2018 with the Cardiology PRN Outstanding Paper of the Year Award for her research regarding CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention.